Cancer Epidemiology, Biomarkers & Prevention, 2026 Low muscle density is associated with morbidity and systemic inflammation in colorectal cancer, independent of tumor factors Aro R., Meriläinen S., Väyrynen J. et al. Olink Target 96OncologyPathophysiologySerum | | | | |
mSystems, 2026 Early-life proteomic and microbiome features signal obesity risk across 26 years of follow-up Ahrens A., Dias R., Hyötyläinen T. et al. Olink Target 96Olink Explore 3072/384Metabolic DiseasesPediatricsPathophysiologyPatient StratificationCord Blood | | | | |
Bioscience Reports, 2026 Apolipoprotein variations across APOE genotypes in young and elderly patients with coronary heart disease Zhang Y., Li S., Xu S. et al. Olink Explore 3072/384CVDCross-platform ValidationPlasma | | | | |
Nature, 2026 Mechanism of age-related accumulation of mtDNA mutations in human blood Gupta R., Durham T., Chau G. et al. Olink Explore 3072/384HematologyAgingPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2026 Integrating Divergence-Based Proteomic Analysis and Directed Network Diffusion to Characterize Diagnosis-Anchored Molecular Variability at the Metabolic Syndrome–Migraine Interface Wang B., Li Y., Liu Y. et al. Olink Explore 3072/384Metabolic DiseasesNeurologyPatient StratificationPlasma | | | | |
Bioinformatics, 2026 Integrated Multi-Omics Strategies for Identifying Novel Therapies in Psoriasis Si S., Wang X., Zhan S. Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma | | | | |
Journal of the European Academy of Dermatology and Venereology, 2026 Tocilizumab for severe and refractory mucous membrane pemphigoid Tedbirt B., Maho‐Vaillant M., Gueudry J. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
eBioMedicine, 2026 Comprehensive longitudinal profiling identifies differential frequency, epitope specificity, and effector function of CD8+ T-cells across COVID-19 disease severities Amaya Hernandez S., Munk K., Danilov K. et al. Olink Target 48Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Cardiovascular Diabetology, 2026 Exerkine dysregulation links visceral adiposity to skeletal muscle impairment in end-stage heart failure with reduced ejection fraction: proteomic evidence for a cardio–adipose–muscle axis Załęska-Kocięcka M., Mazuruk M., Szcześniak K. et al. Olink Explore HTCVDOther Diseases & SyndromesAgingPathophysiologyPlasma | | | | |
Brain, Behavior, and Immunity, 2026 Psychosocial stress in the first 25 years of life and cognitive function in midlife: the role of inflammation Wang X., Harris R., Liu Y. et al. RevealNeurologyPathophysiologyPlasma | | | | |
Journal of Investigative Dermatology, 2026 Hirsutism Beyond PCOS: Genome-wide Evidence for Genetic Factors Takala J., Pujol-Gualdo N., Laisk T. et al. Olink Explore 3072/384Other Diseases & SyndromesEndocrinologyPathophysiologyPlasma | | | | |
Brain, Behavior, and Immunity, 2026 Positive childhood experiences and associations with plasma inflammatory markers in early adulthood Murphy J., Gilheany J., Mongan D. et al. Olink Target 96Environmental Health & ToxicologyPathophysiologyPlasma | | | | |
Journal of Clinical Medicine, 2026 Identification of Inflammatory Markers for the Prediction and Diagnosis of Diminished Ovarian Reserve Using Olink Targeted Proteomics Li M., Zhang Y., Yu L. et al. Olink Target 96ObstetricsGynecologyPatient StratificationFollicular Fluid | | | | |
Nature Communications, 2026 Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial Johnson J., Miller J., Hatoum F. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Nature Communications, 2026 Genome-wide meta-analysis identifies genetic drivers of bile acid metabolism in intrahepatic cholestasis of pregnancy Tyrmi J., Karjalainen J., Venkatesh S. et al. Olink Explore 3072/384HepatologyObstetricsPathophysiologyPlasma | | | | |
Brain, Behavior, and Immunity, 2026 Childhood immunomodulatory biomarkers and risk of depression and psychosis-spectrum outcomes at age 24: longitudinal evidence from the ALSPAC birth cohort Ghelfi L., Mongan D., Murphy J. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Medicine, 2026 Causal effects of plasma protein–protein ratios on lung cancer subtypes: A proteome-wide Mendelian randomization and mediation analysis Geng X., Xue J., Liu K. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Medicine, 2026 Inflammatory factors and hypertensive nephropathy: A bidirectional 2-sample Mendelian randomization study Yang Y., Xue J., Wang L. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Journal of Global Health, 2026 Genetic and epidemiological analyses of alcohol consumption patterns and age-related macular degeneration risk among current drinkers: a role for TNFRSF10A Shen T., Li J., Yang X. et al. Olink Explore 3072/384OphthalmologyPathophysiologyPlasma | | | | |
Annals of Neurology, 2026 Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis Ding Y., Hamitouche D., Thebault S. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |